Emcure Pharmaceuticals inks pact to purchase electricity generated from TUPL

03 Jun 2025 Evaluate

Emcure Pharmaceuticals has entered into a Share Subscription and Shareholders’ Agreement and Power Transfer Agreement(s) dated June 02, 2025 to purchase the electricity generated from Torrent Urja 37 (TUPL), in accordance with the provisions of the aforesaid Agreement(s) to meet its energy requirements at identified facilities in the state of Gujarat. Cost of acquisition is Rs 3.72 crore. 

The completion of the acquisition is subject to the receipt of all consents, permissions required to be obtained by TUPL from regulatory authority for open access for captive consumption of electricity.

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. 


Emcure Pharma Share Price

1395.15 -9.10 (-0.65%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×